can tirzepatide cause hives Allergic Reactions to Tirzepatide: Symptoms and Management A Case Report of Systemic

In August 2025 , the FDA approved Wegovy for another use: to treat a type of fatty liver disease called metabolic dysfunction-associated steatohepatitis (MASH) in adults who have moderate to advanced liver scarring (fibrosis) but do not have permanent liver damage (cirrhosis)

Read the full Refund Policy before submitting any payment

During active weight loss, your body is breaking down stored fat at an accelerated rate

Implications for employers: The cardiac benefits of semaglutide are not completely dependent on weight loss or initial BMI prior to treatment

Beyond 6 months of chronic undereating: Menstrual irregularities or loss

While a single warm-to-cold transition is unlikely to cause dramatic degradation, the manufacturer has not tested repeated cycling, so they cannot guarantee stability under those conditions